Please enable JavaScript to continue using this application.

Compare $ALDX vs $INKT | Chartloom

Compare

$ALDX vs $INKT

Aldeyra Therapeutics Inc · Mink Therapeutics Inc

ALDX

Aldeyra Therapeutics Inc

INKT

Mink Therapeutics Inc

Compare $ALDX vs $INKT

Comparing Aldeyra Therapeutics Inc and Mink Therapeutics Inc

ALDXAldeyra Therapeutics Inc

INKTMink Therapeutics Inc

ALDXAldeyra Therapeutics Inc

Market cap

$55M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.4%

52W performance

-83.7%

FCF yield

-39.9%

INKTMink Therapeutics Inc

Market cap

$53M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.6%

52W performance

-26.5%

FCF yield

-12.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALDX

INKT

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

INKT

Mink Therapeutics Inc

Market Cap

ALDX$55M

INKT$53M

Enterprise Value

ALDX$10M

INKT$45M

Price

ALDX$0.92

INKT$10.72

P/E Ratio

ALDXN/A

INKTN/A

P/S Ratio

ALDX0.00x

INKT0.00x

EV/Sales

ALDX0.00x

INKT0.00x

EV/EBITDA

ALDX0.00x

INKT0.00x

P/B Ratio

ALDX1.86x

INKT9.40x

P/FCF Ratio

ALDXN/A

INKTN/A

EV/FCF

ALDX-0.46x

INKT-6.53x

PEG Ratio

ALDXN/A

INKTN/A

Forward P/E (NTM)

ALDXN/A

INKTN/A

Forward P/S (NTM)

ALDXN/A

INKTN/A

Revenue (TTM)

ALDX$0

INKT$0

Revenue Growth (YoY)

ALDXN/A

INKTN/A

Forward Rev Growth

ALDX298.2%

INKT17.6%

Gross Margin (TTM)

ALDX0.0%

INKT0.0%

Operating Margin (TTM)

ALDX0.0%

INKT0.0%

EBITDA Margin (TTM)

ALDX0.0%

INKT0.0%

Net Margin (TTM)

ALDX0.0%

INKT0.0%

FCF Margin (TTM)

ALDXN/A

INKTN/A

Net Income (TTM)

ALDX$-23M

INKT$-11M

FCF (TTM)

ALDX$-22M

INKT$-7M

EPS (TTM)

ALDX-$0.38

INKT-$2.26

ROE (TTM)

ALDX-5314.0%

INKT-16887.0%

ROA (TTM)

ALDX-3494.0%

INKT-9237.0%

ROIC (TTM)

ALDX-4205.0%

INKT-16887.0%

Cash

ALDX$45M

INKT$9M

Debt

ALDX$0

INKT$0

Net Cash/Debt

ALDX$45M

INKT$9M

Current Ratio (TTM)

ALDX4.91x

INKT1.23x

Quick Ratio (TTM)

ALDX4.74x

INKT1.19x

Debt/Equity (TTM)

ALDX0.34x

INKT0.00x

Debt/Assets (TTM)

ALDX0.0%

INKT0.0%

Interest Coverage (TTM)

ALDXN/A

INKTN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

INKT0.00x

Beta

ALDX1.21

INKT0.45

52W Performance

ALDX-83.7%

INKT-26.5%

YTD Performance

ALDX-80.4%

INKT-3.6%

% from 52W High

ALDX-84.5%

INKT-36.7%

% from 52W Low

ALDX6.3%

INKT26.4%

Asset Turnover (TTM)

ALDX0.00x

INKT0.00x

FCF Yield (TTM)

ALDX-39.9%

INKT-12.8%

Earnings Yield (TTM)

ALDX-41.7%

INKT-21.3%

Dividend Yield (TTM)

ALDXN/A

INKTN/A

Rule of 40

ALDX0.0

INKT0.0

EV/GP/RG

ALDXN/A

INKTN/A

Ticker research

View ALDX research View INKT research

Metric	ALDX Aldeyra Therapeutics Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$55M	$53M
Enterprise Value	$10M	$45M
Price	$0.92	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-11M
FCF (TTM)	$-22M	$-7M
EPS (TTM)	-$0.38	-$2.26
ROE (TTM)	-5314.0%	-16887.0%
ROA (TTM)	-3494.0%	-9237.0%
ROIC (TTM)	-4205.0%	-16887.0%
Financial Health
Cash	$45M	$9M
Debt	$0	$0
Net Cash/Debt	$45M	$9M
Current Ratio (TTM)	4.91x	1.23x
Quick Ratio (TTM)	4.74x	1.19x
Debt/Equity (TTM)	0.34x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.45
52W Performance	-83.7%	-26.5%
YTD Performance	-80.4%	-3.6%
% from 52W High	-84.5%	-36.7%
% from 52W Low	6.3%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-12.8%
Earnings Yield (TTM)	-41.7%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View INKT research

Valuation

P/S Ratio

ALDX

0.00x

INKT

0.00x

EV/FCF

INKT

-6.53x

ALDX

-0.46x

Growth & revenue

Forward Revenue Growth

ALDX

298.2%

INKT

17.6%

Profitability & performance

Gross Margin

ALDX

0.0%

INKT

0.0%

ROE

ALDX

-5314.0%

INKT

-16887.0%

FCF Yield %

INKT

-12.8%

ALDX

-39.9%

52-Week Performance

INKT

-26.5%

ALDX

-83.7%

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

INKT

Mink Therapeutics Inc

Market Cap

ALDX$55M

INKT$53M

Enterprise Value

ALDX$10M

INKT$45M

Price

ALDX$0.92

INKT$10.72

P/E Ratio

ALDXN/A

INKTN/A

P/S Ratio

ALDX0.00x

INKT0.00x

EV/Sales

ALDX0.00x

INKT0.00x

EV/EBITDA

ALDX0.00x

INKT0.00x

P/B Ratio

ALDX1.86x

INKT9.40x

P/FCF Ratio

ALDXN/A

INKTN/A

EV/FCF

ALDX-0.46x

INKT-6.53x

PEG Ratio

ALDXN/A

INKTN/A

Forward P/E (NTM)

ALDXN/A

INKTN/A

Forward P/S (NTM)

ALDXN/A

INKTN/A

Revenue (TTM)

ALDX$0

INKT$0

Revenue Growth (YoY)

ALDXN/A

INKTN/A

Forward Rev Growth

ALDX298.2%

INKT17.6%

Gross Margin (TTM)

ALDX0.0%

INKT0.0%

Operating Margin (TTM)

ALDX0.0%

INKT0.0%

EBITDA Margin (TTM)

ALDX0.0%

INKT0.0%

Net Margin (TTM)

ALDX0.0%

INKT0.0%

FCF Margin (TTM)

ALDXN/A

INKTN/A

Net Income (TTM)

ALDX$-23M

INKT$-11M

FCF (TTM)

ALDX$-22M

INKT$-7M

EPS (TTM)

ALDX-$0.38

INKT-$2.26

ROE (TTM)

ALDX-5314.0%

INKT-16887.0%

ROA (TTM)

ALDX-3494.0%

INKT-9237.0%

ROIC (TTM)

ALDX-4205.0%

INKT-16887.0%

Cash

ALDX$45M

INKT$9M

Debt

ALDX$0

INKT$0

Net Cash/Debt

ALDX$45M

INKT$9M

Current Ratio (TTM)

ALDX4.91x

INKT1.23x

Quick Ratio (TTM)

ALDX4.74x

INKT1.19x

Debt/Equity (TTM)

ALDX0.34x

INKT0.00x

Debt/Assets (TTM)

ALDX0.0%

INKT0.0%

Interest Coverage (TTM)

ALDXN/A

INKTN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

INKT0.00x

Beta

ALDX1.21

INKT0.45

52W Performance

ALDX-83.7%

INKT-26.5%

YTD Performance

ALDX-80.4%

INKT-3.6%

% from 52W High

ALDX-84.5%

INKT-36.7%

% from 52W Low

ALDX6.3%

INKT26.4%

Asset Turnover (TTM)

ALDX0.00x

INKT0.00x

FCF Yield (TTM)

ALDX-39.9%

INKT-12.8%

Earnings Yield (TTM)

ALDX-41.7%

INKT-21.3%

Dividend Yield (TTM)

ALDXN/A

INKTN/A

Rule of 40

ALDX0.0

INKT0.0

EV/GP/RG

ALDXN/A

INKTN/A

Ticker research

View ALDX research View INKT research

Metric	ALDX Aldeyra Therapeutics Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$55M	$53M
Enterprise Value	$10M	$45M
Price	$0.92	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-11M
FCF (TTM)	$-22M	$-7M
EPS (TTM)	-$0.38	-$2.26
ROE (TTM)	-5314.0%	-16887.0%
ROA (TTM)	-3494.0%	-9237.0%
ROIC (TTM)	-4205.0%	-16887.0%
Financial Health
Cash	$45M	$9M
Debt	$0	$0
Net Cash/Debt	$45M	$9M
Current Ratio (TTM)	4.91x	1.23x
Quick Ratio (TTM)	4.74x	1.19x
Debt/Equity (TTM)	0.34x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.45
52W Performance	-83.7%	-26.5%
YTD Performance	-80.4%	-3.6%
% from 52W High	-84.5%	-36.7%
% from 52W Low	6.3%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-12.8%
Earnings Yield (TTM)	-41.7%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View INKT research